Pharma Journalist 9023 posts 0 comments

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene autoleucel; cilta-cel)…
Read More...

Edenbridge Pharmaceuticals, LLC announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub…
Read More...

EMA’s human medicines committee (CHMP) has recommended that a booster dose of the COVID-19 vaccine Comirnaty may be given where appropriate to adolescents from 12 years of age.…
Read More...

Merck, known as MSD outside the United States and Canada, and Eisai announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of KEYTRUDA,…
Read More...

Virios Therapeutics, Inc. a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases, including fibromyalgia, announced a…
Read More...

Taro Pharmaceutical Industries Ltd. announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s…
Read More...

Actym Therapeutics, a biotechnology company focused on the discovery and development of novel therapies intended to transform the treatment of cancer, and Wacker Biotech announced today…
Read More...

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) announced that Health Canada has granted approval for COVIFENZ, COVID-19 vaccine,…
Read More...

Shionogi & Co., Ltd. announced that Shionogi has completed the analysis of primary endpointsa), b) in the Phase 2b part of a Phase 2/3 clinical trial of S-217622, an orally…
Read More...

SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA…
Read More...